{"name":"Sewon Cellontech Co., Ltd.","slug":"sewon-cellontech-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CHONDRON","genericName":"CHONDRON","slug":"chondron","indication":"Cartilage defects of the knee","status":"phase_3"}]}],"pipeline":[{"name":"CHONDRON","genericName":"CHONDRON","slug":"chondron","phase":"phase_3","mechanism":"CHONDRON is an autologous chondrocyte-based cell therapy that regenerates cartilage tissue by implanting a patient's own expanded cartilage cells into damaged joint areas.","indications":["Cartilage defects of the knee","Osteoarthritis of the knee"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9KZHltTmx4MThzQmIwb2U0WERsM2dveGk2bEsyeFFtREZXXzRqUW80ekJwdmFYUDBCdzZVTWs0SURtSFBrX2pSOXpuaGkzcE02cUVwanplVkNycWNoeGMzZjVCR3ByX1BXVUMtNtIBcEFVX3lxTFBjck5UVDQ3U3pySFFwZ1Y5d3Z4YWNLM3VPYk0xLWhoc1BXRTBuRF8xODQzX0VqM2lyaHNsd01LSzliR2hqYVNUV093SFZhVGVacWJuSjUzZ0xJUDAweElZczZaWnJvbEVmQnFfWWtOdzk?oc=5","date":"2017-12-04","type":"trial","source":"koreabiomed.com","summary":"Sewon seeks p3 clinical trials for cartilage cell therapy in Japan - koreabiomed.com","headline":"Sewon seeks p3 clinical trials for cartilage cell therapy in Japan","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}